Jan 21 (Reuters) - Abcellera Biologics Inc ABCL.O :
* ABCELLERA-DISCOVERED ANTIBODY PREVENTED COVID-19 IN NURSING HOMES AND REDUCED RISKS BY UP TO 80% FOR RESIDENTS
* ABCELLERA BIOLOGICS INC - BAMLANIVIMAB REDUCED RISK OF CONTRACTING COVID-19 BY UP TO 80% IN RESIDENTS VERSUS PLACEBO
* ABCELLERA BIOLOGICS INC - THERE WERE NO COVID-19-RELATED DEATHS OF PARTICIPANTS RECEIVING BAMLANIVIMAB